|
| Analyst
Scorecard | | Analyst: | Duncan, Charles | EPS
Est. Accuracy: | Not Avl.
| | Broker: | JMP Securities | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
| Not Avl.
|
4.1%
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
ACAD
|
Acadia Pharmaceuticals Inc
|
|
4
| | | | |
ALTH
|
Allos Therapeutics
| 
|
9
| | | | |
ALXA
|
Alexza Pharmaceuticals Inc
|
|
4
| | | | |
CADX
|
Cadence Pharmaceuticals Inc
|
|
7
| | | | |
CELG
|
Celgene Corporation
|
|
23
| | | | |
CEPH
|
Cephalon Inc
|
|
22
| | | | |
CYTK
|
Cytokinetics Inc
|
|
5
| | | | |
GHDX
|
Genomic Health Inc
|
|
8
| | | | |
MYGN
|
Myriad Genetics Inc
|
|
18
| | | | |
OREX
|
Orexigen Therapeutics Inc
|
|
7
| | | | |
OSIR
|
Osiris Therapeutics Inc
| 
|
5
| | | | |
PDLI
|
Pdl Biopharma Inc
|
|
7
| | | | |
SGMO
|
Sangamo Biosciences Inc
|
|
8
| | | |
| Other Stocks Covered
| |
Biocryst Pharmaceuticals, Inc. (BCRX), Celera Corp (CRA)
|
| | |
|
|
|